Publications

5803 Results

Prognostic Value of Circulating Tumor DNA in Advanced Stage Classic Hodgkin Lymphoma Patients Treated on SWOG S1826

Authors
J Paczkowska;M Kaczkowiak;M LeBlanc;C Stewart;A Herrera;J Fernando del Castillo;S Castellino;S Rutherford;A Evens;K Davison;H Li;D Neuberg;M Murakami;J Makker;B Kahl;J Leonard;N Bartlett;S Smith;J Song;K Kelly;G Getz;JW Friedberg;M Shipp
Journal / Conference
ICML 2025 Meeting (Lugano, Switzerland, from 17 to 21 June 2025)
Year
2025
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Baseline autoimmune diseases and characteristics of solid tumor patients on immune checkpoint inhibitor (ICI) therapy enrolled in a prospective study of immune-related adverse events (irAEs): SWOG S2013 (I-CHECKIT)

Authors
K Gunturu;J Unger;D Hershman;A Darke;N Kuderer;S Hu-Lieskovan;J Nabi;M Sochat;NL Henry;M Fisch
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster, Abstract # 2600 Poster Bd # 247
Year
2025
Research Committee(s)
Symptom Management and Survivorship
Study Number(s)
S2013

Efficacy and Toxicity of Nivolumab and Ipilimumab in Rare Cancer Brain Metastases: A Multi-Center Basket Trial Analysis (NCI/SWOG S1609)

Authors
M Ahluwalia;S Solomon;S Patel;S Sarfraz;M Othus;Y Chae;R Kurzrock
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster; Abstract # 2619 Poster Bd # 266
Year
2025
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC)

Authors
D Bsteh;J Buckley;S Mitchell;D Ostrow;J Parmentier;S Jahan;S Sadis;J Smith;J Ni;X Peng;D McConkey;T Dorff;S Lerner;A Aparicio;B Chapin;V Duddalwar;T Triche;A Goldkorn
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), publication only, Abstract # e17111
Year
2025
Research Committee(s)
Genitourinary
Study Number(s)
S1802

SWOG S2302, PRAGMATICA-LUNG: A Pragmatic Trial Designed to Increase Participant Representation

Authors
K Reckamp;M Redman;K Dragnev;M Khalil;B Henick;J Moon;P Ahmadzai;M LeBlanc;D Carrizosa;R Herbst;C Blanke;J Gray
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), rapid oral, Abstract # 11016
Year
2025
Research Committee(s)
Lung
Study Number(s)
S2302

SWOG/NRG S1914: A Randomized Phase III Trial of Induction/Consolidation Atezolizumab + SBRT versus SBRT Alone in High Risk, Early-Stage NSCLC

Authors
C Simone;M Daly;M Redman;M Hsiah;J Gray;P Hesketh;C Hu;A Monjazeb;C Steuer;A Ganti;R Kashani;J Bauman;J Feliciano;J Moon;J Miao;K Ku;A Onitilo;K Kelly;J Bradley
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), oral, Abstract # 8003
Year
2025
Research Committee(s)
Lung
Study Number(s)
S1914

Comparing impact of treatment before or after surgery in patients with stage II-IIIb resectable non-small cell lung cancer (NSCLC; Alliance A082304-SWOG S2402).

Authors
R Aljumaily;S Manrekar;Y Zhao;L Martin;D Kozono;S Hillman;A Chiang;R Osarogiagbon;T Stinchcombe;J Gray;D Morgensztern
Journal / Conference
ASCO Annual Meeting (May 30 to June 3, 2025, Chicago, Il), poster; Abstract # TPS8113 Poster Bd # 234a
Year
2025
Research Committee(s)
Lung
Study Number(s)
CTSU/A082304/S2402

Urinary outcomes of International Prostate Symptom Score phenotypes following transurethral resection of the prostate: a secondary analysis of the Prostate Cancer Prevention Trial

Authors
C Chestnut;O Phelps;S Holt;J Schenk
Journal / Conference
World Congress of Endourology (Sept 8-12, 2025, Phoenix, AZ)
Year
2025
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

Patient-reported outcomes (PROs) in the pragmatic comparative effectiveness trial of surgical versus non-surgical management for patients with malignant bowel obstruction (S1316)

Authors
A Dueck;K Arnold;G Anderson;C Thomson;A Secord;G Deutsch;J Deneve;R Krouse
Journal / Conference
ISOQOL Meeting (22-25 October 2025 Milwaukee, WI)
Year
2025
Research Committee(s)
Palliative Care
Study Number(s)
S1316

EXTERNAL VALIDATION OF A POLYGENIC RISK SCORE FOR TAXANE-INDUCED PERIPHERAL NEUROPATHY: RESULTS FROM THE SWOG S0221 CLINICAL TRIAL

Authors
N Nguyen-Hoang;L Sucheston-Campbell;G Budd;L Pusztai;C Ambrosone;D Hertz
Journal / Conference
Pharmacogenomics Research Network (PGRN) 2025 Annual Meeting (September 10-12, 2025, Mkssoula, MT)
Year
2025
Research Committee(s)
Breast
Study Number(s)
S0221